Shenzhen Neptunus Bioengineering Co., Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Dec'23

Net Sales

6,916.26

7,356.51

5,737.04

7,898.18

8,518.94

8,065.01

7,749.06

Other Operating Income

0.00

Total Operating income

6,916.26

7,356.51

5,737.04

7,898.18

8,518.94

8,065.01

7,749.06

Raw Material Cost

6,325.88

6,735.23

5,391.63

7,232.29

7,759.22

7,291.07

7,244.20

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

150.54

147.12

259.47

173.80

169.88

205.62

335.44

Selling and Distribution Expenses

396.71

474.32

901.15

457.96

488.33

463.00

936.06

Other Expenses

-14.11

-13.68

-25.46

-16.42

-15.94

-19.64

-32.55

Total Expenditure (Excl Depreciation)

6,732.06

7,219.85

6,297.62

7,699.87

8,258.02

7,763.26

8,190.18

Operating Profit (PBDIT) excl Other Income

184.20000000000002

136.7

-560.6

198.29999999999998

260.9

301.70000000000005

-441.1

Other Income

8.17

98.22

-11.50

25.15

-3.31

24.38

-53.05

Operating Profit (PBDIT)

246.18

291.91

-543.70

288.26

323.30

387.31

-1,375.13

Interest

150.54

147.12

259.47

173.80

169.88

205.62

335.44

Exceptional Items

0.05

0.02

-481.43

9.77

0.14

0.12

17.47

Gross Profit (PBDT)

590.38

621.27

345.41

665.89

759.71

773.94

504.86

Depreciation

54.07

70.28

60.22

78.48

Profit Before Tax

41.61

90.75

-1,354.88

53.95

93.33

121.59

-1,771.57

Tax

30.05

37.80

-57.42

43.27

47.29

52.47

104.61

Provisions and contingencies

0.00

Profit After Tax

7.97

23.72

-1,239.63

0.81

2.77

42.64

-1,778.43

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

7.97

23.72

-1,239.63

0.81

2.77

42.64

-1,778.43

Share in Profit of Associates

0.00

Minority Interest

3.90

29.24

-53.52

9.76

43.34

26.53

-126.62

Other related items

0.00

Consolidated Net Profit

11.87

52.96

-1,293.16

10.56

46.11

69.17

-1,905.04

Equity Capital

0.00

Face Value

1.0

Reserves

1,829.80

1,818.96

1,795.23

3,035.90

3,047.54

3,045.56

3,002.92

Earnings per share (EPS)

0.0

0.01

-0.47

0.0

0.02

-0.68

Diluted Earnings per share

0.0

0.01

-0.47

0.0

0.02

-0.68

Operating Profit Margin (Excl OI)

2.66%

1.9%

-10.5%

2.44%

3.13%

3.75%

-18.07%

Gross Profit Margin

1.38%

1.97%

-22.39%

1.57%

1.8%

2.25%

-21.85%

PAT Margin

0.12%

0.32%

-21.61%

0.01%

0.03%

0.53%

-22.95%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Jun 2025 is -5.98% vs 28.23% in Mar 2025

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is -77.55% vs 104.10% in Mar 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 22.87% vs 136.40% in Mar 2025

Interest

QoQ Growth in quarter ended Jun 2025 is 2.31% vs -43.31% in Mar 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Shenzhen Neptunus Bioengineering Co., Ltd. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(CNY)

Change(%)

Net Sales

6,916.26

Other Operating Income

0.00

Total Operating income

6,916.26

Raw Material Cost

6,325.88

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

150.54

Selling and Distribution Expenses

396.71

Other Expenses

-14.11

0.00

-14.11

Total Expenditure (Excl Depreciation)

6,732.06

Operating Profit (PBDIT) excl Other Income

184.20

0.00

184.20

Other Income

8.17

Operating Profit (PBDIT)

246.18

Interest

150.54

Exceptional Items

0.05

Gross Profit (PBDT)

590.38

Depreciation

54.07

Profit Before Tax

41.61

Tax

30.05

Provisions and contingencies

0.00

Profit After Tax

7.97

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

7.97

Share in Profit of Associates

0.00

Minority Interest

3.90

Other related items

0.00

Consolidated Net Profit

11.87

Equity Capital

0.00

Face Value

1.00

0.00

Reserves

1,829.80

Earnings per share (EPS)

0.00

Diluted Earnings per share

0.00

Operating Profit Margin (Excl OI)

2.66%

0.00

2.66%

Gross Profit Margin

1.38%

0.00

1.38%

PAT Margin

0.12%

0.00

0.12%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 691.63 Million

in Jun 2025

Figures in Million

QoQ Growth in quarter ended Jun 2025 is -5.98% vs 28.23% in Mar 2025

YoY Growth in quarter ended Jun 2025 is -18.81% vs -14.56% in Jun 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 1.19 Million

in Jun 2025

Figures in Million

QoQ Growth in quarter ended Jun 2025 is -77.55% vs 104.10% in Mar 2025

YoY Growth in quarter ended Jun 2025 is -74.19% vs -14.15% in Jun 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 23.80 Million

in Jun 2025

Figures in Million

QoQ Growth in quarter ended Jun 2025 is 22.87% vs 136.40% in Mar 2025

YoY Growth in quarter ended Jun 2025 is -27.13% vs -17.75% in Jun 2024

Quarterly - Interest

Interest 15.05 Million

in Jun 2025

Figures in Million

QoQ Growth in quarter ended Jun 2025 is 2.31% vs -43.31% in Mar 2025

YoY Growth in quarter ended Jun 2025 is -11.42% vs -14.19% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 2.66%

in Jun 2025

Figures in %

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024